Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 39.11B | 40.10B | 36.10B | 34.54B | 31.40B | 31.67B |
Gross Profit | 8.71B | 8.81B | 7.72B | 7.06B | 6.77B | 6.60B |
EBITDA | 2.20B | 2.54B | 1.99B | 1.58B | 1.83B | 242.25M |
Net Income | 1.06B | 1.05B | 779.85M | 331.34M | 750.84M | -847.08M |
Balance Sheet | ||||||
Total Assets | 28.00B | 27.68B | 28.36B | 27.20B | 27.05B | 24.89B |
Cash, Cash Equivalents and Short-Term Investments | 7.67B | 7.10B | 8.48B | 8.26B | 7.56B | 6.49B |
Total Debt | 4.06B | 2.87B | 4.98B | 5.13B | 3.82B | 3.33B |
Total Liabilities | 12.39B | 11.73B | 13.14B | 13.00B | 13.22B | 11.36B |
Stockholders Equity | 15.61B | 15.95B | 15.22B | 14.20B | 13.82B | 13.53B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 831.48M | 924.34M | -502.24M | 345.68M | 1.30B |
Operating Cash Flow | 0.00 | 3.12B | 1.68B | 790.45M | 1.75B | 2.51B |
Investing Cash Flow | 0.00 | -2.43B | -1.20B | -1.21B | -889.09M | -1.31B |
Financing Cash Flow | 0.00 | -2.24B | -253.79M | 1.16B | 310.62M | 607.72M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥5.52B | 5.30 | 2.33% | 11.07% | 34.18% | ||
75 Outperform | ¥5.54B | 9.99 | 3.69% | 10.05% | 8.17% | ||
74 Outperform | ¥6.14B | 12.67 | 1.75% | 3.62% | 40.39% | ||
73 Outperform | ¥5.53B | 9.55 | 1.20% | -3.54% | 0.10% | ||
69 Neutral | ¥5.70B | 13.19 | 4.08% | 0.20% | -40.35% | ||
65 Neutral | $10.81B | 15.65 | 5.50% | 1.89% | 3.10% | -27.09% | |
51 Neutral | ¥5.28B | ― | 2.07% | -2.05% | -14.68% |